# Billion-euro innovation in the field: Bayer's plan to lead the next technological generation of agriculture

With 2 billion euros and a focus on developing ten major innovations by the end of the decade, the German multinational is decentralizing its research operations and putting the Brazilian market at the center of its global strategy.

- Section: Agribusiness
- Published: October 19, 2026
- Address: https://ceoone.com.br/en/article/billion-euro-innovation-in-the-field-bayer-plan-to-lead-the-next
- Em português: https://ceoone.com.br/artigo/inovacao-bilionaria-no-campo-o-plano-da-bayer-para-liderar-a-proxima-g.md

![Aerial view of a circular building with the Bayer cross in the center of the inner garden](https://pub-b80e49b2737940b3ab5d3f20d0578192.r2.dev/artigos/inovacao-bilionaria-no-campo-o-plano-da-bayer-para-liderar-a-proxima-g-foto.webp)

Photo: Reproduction/Bayer

## Key points

- Bayer's Crop Science is investing 2 billion euros to launch ten major innovations by 2030, seven of them in biotechnology.
- Four of these innovations are expected to reach Brazilian farms directly; Brazil now takes part in originating the projects, not just receiving them.
- The company says its research budget is separate from the herbicide lawsuits in the United States.

The next big harvest the world's agribusiness hopes to reap does not depend only on weather conditions in the field, but on accelerated progress in research and development labs. In a strong capital expansion move, Bayer's Crop Science division has set up a 2-billion-euro investment cycle aimed at creating cutting-edge technologies that promise to redefine productivity, efficiency and sustainability on farms worldwide. The company's central goal is to bring to the international market a new generation of high-impact solutions, known in the industry as blockbusters, designed to meet growing demands for food security and climate adaptation.

The German multinational's strategic plan calls for ten major commercial launches on the global agricultural market by 2030, seven of them strictly in biotechnology. The organization's global executives point out that the simultaneous convergence of scientific innovations in areas such as advanced breeding, bio-inputs and digital farming tools creates an unprecedented ecosystem for modernizing large-scale agricultural production.

## Brazil as a source and origin of technological innovation

One of the most significant consequences of this new corporate phase is a deep change in the company's product development path, which has given Brazil a leading role in conceiving new solutions. Traditionally seen only as a receptive consumer market for inputs formulated abroad, Brazil's agricultural ecosystem has become part of the very origin of the company's creative and scientific process.

This operational decentralization breaks with the traditional corporate model: instead of concentrating all portfolio decisions at global headquarters for later regional validation, Bayer gave local teams more autonomy to identify and meet the specific demands of South American agriculture. Of the ten large projects planned for the international portfolio through 2030, four high-value biotech innovations are expected to be applied directly on Brazilian farms, showing the country's strategic weight in global agriculture.

## Shielding investment and keeping distance from international litigation

The technological offensive led by the multinational is moving ahead amid intense regulatory and legal scrutiny in developed markets, notably the lawsuits the company faces in the United States over traditional herbicides. Despite the financial significance of these disputes concentrated in the US market, the organization's senior research leadership has reiterated the strict separation between the local litigation and the long-term strategic planning for its scientific portfolio.

Global management stresses that the resources allocated to research and development remain fully protected, with the capital dedicated exclusively to supporting the transition to a more resilient production model. The corporation thus ensures that its operations remain focused on delivering the biotech solutions needed to meet future demands for productivity and sustainability in the field.

## The outlook for global agricultural productivity

The corporate race toward higher levels of technological efficiency shows the urgency of tools able to raise crop yields without expanding the agricultural frontier at the same rate. The ability to turn billion-euro investments into practical, accessible results for farmers will define the competitiveness of the companies that lead the sector in the coming decades.

By moving Brazil to the center of its technological development and devoting significant resources to cutting-edge biotechnology, Bayer signals that the future of world agriculture will depend on deep integration between scientific rigor, regional reach and the capacity to adapt. The success of this venture will represent not only a financial milestone for the corporation, but a structural change in how the planet secures its food production.

## Sources and editorial notes

- Reference reporting and data: Exame Agro, Bayer's Crop Science division.

CEO ONE · https://ceoone.com.br